AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1633897
Drug: Anticoagulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulation therapy in pregnancy (18 patients)
Trial: 1633897
Drug: Combined study
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined study groups (anticardiolipin antibody-positive vs. negative)
Trial: 6385838
Drug: Furazolidone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furazolidone (100 mg four times daily for 5 days)
Trial: 6385838
Drug: Ampicillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin (500 mg four times daily for 5 days)
Trial: 28566122
Drug: Standardized weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized weekly exchange of nasogastric feeding tubes
Trial: 15575918
Drug: Everolimus (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus (1.5 mg/day)
Trial: 18089377
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) (3 g/day)
Trial: 26621156
Drug: 50 mg/d
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/d lisdexamfetamine dimesylate (LDX)
Trial: 26621156
Drug: 70 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg/d lisdexamfetamine dimesylate (LDX)
Trial: 26621156
Drug: 30 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/d lisdexamfetamine dimesylate (LDX)
Trial: 22964730
Drug: Peritoneal irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritoneal irrigation with a minimum of 500 mL normal saline
Trial: 14616458
Drug: tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine ER 4 mg once daily
Trial: 15948744
Drug: oxybutynin 3
RxNorm normalized name: oxyBUTYnin 3 % Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxybutynin 3 mg three times daily
Trial: 7031516
Drug: 60 mg/day
RxNorm normalized name: cabozantinib s-malate 60 mg/day (20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/day bromopride for 15 days
Trial: 31161388
Drug: Cognitive Stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Stimulation Therapy (CST-PD) for 12 weeks
Trial: 24870446
Drug: Oral SGAs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral SGAs
Trial: 18514614
Drug: Self-help cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-help cognitive behavioral treatment with minimal therapist contact
Trial: 17596915
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg dihydrexidine
Trial: 12929472
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment (including angiotensin-converting enzyme inhibitors and angiotensin receptor blockers)
Trial: 12929472
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antihypertensive agents with diuretics
Trial: 12929472
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of angiotensin-converting enzyme inhibitor and diuretic as first-line treatment
Trial: 8650997
Drug: Low‐energetic extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐energetic extracorporeal shock wave therapy (1000 impulses, energy density 0.06 mJ/mm2, administered 3 times in weekly intervals)
Trial: 8650997
Drug: Low‐energetic extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐energetic extracorporeal shock wave therapy
Trial: 3525431
Drug: Coenzyme A
RxNorm normalized name: Coenzyme A
DrugBank: Coenzyme A (DB01992)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coenzyme A (2,000 Lipmann U daily) administered intravenously for 20 days
Trial: 3525431
Drug: Sulodexide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide (300 Lipasemic U daily) administered intravenously for 20 days
Trial: 30204554
Drug: Active PPARγ
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active PPARγ agonist pioglitazone (45 mg)
Trial: 27904554
Drug: Helicobacter pylori
RxNorm normalized name: HELICOBACTER PYLORI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helicobacter pylori eradication treatment (four-drug regimen)
Trial: 27904554
Drug: Placebo (capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (capsules and tablets)
Trial: 25066248
Drug: Antepartum dalteparin
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antepartum dalteparin (5000 international units once daily up to 20 weeks' gestation, and twice daily thereafter until at least 37 weeks' gestation)
Trial: 18492125
Drug: Etravirine alone
RxNorm normalized name: Etravirine
DrugBank: Etravirine (DB06414)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Etravirine alone (100 mg)
Trial: 18492125
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg b.i.d. for 11 days) + Etravirine (100 mg on day 8)
Trial: 18492125
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg q.d. for 11 days) + Etravirine (100 mg on day 8)
Trial: 16825031
Drug: Cinacalcet HCl
RxNorm normalized name: cinacalcet HCl
DrugBank: Cinacalcet (DB01012)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cinacalcet HCl (30 to 180 mg/day)
Trial: 10780128
Drug: Intensive outpatient
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive outpatient treatment
Trial: 1442677
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg triglycyl‐lysin‐vasopressin
Trial: 6363935
Drug: 4.8 million
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.8 million units of aqueous procaine penicillin plus 1 g of probenecid
Trial: 6363935
Drug: nine tablets
RxNorm normalized name: Arginine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nine tablets of trimethoprim‐sulfamethoxazole daily for three days
Trial: 6363935
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of tetracycline four times a day for five days
Trial: 16021438
Drug: Manidipine 10
RxNorm normalized name: manidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine 10 mg o.d.
Trial: 16021438
Drug: Lisinopril 10
RxNorm normalized name: lisinopril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 10 mg o.d.
Trial: 10981241
Drug: Apothecon warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apothecon warfarin
Trial: 10981241
Drug: DuPont warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DuPont warfarin
Trial: 10981241
Drug: Apothecon warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apothecon warfarin and DuPont warfarin
Trial: 8834418
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg oral test dose of haloperidol (HPDL) followed by maintenance doses of 2, 5 to 8, or 10 to 15 mg twice daily for 5 days to achieve low (< 5 ng/ml), medium (10-18 ng/ml), or high (> 25 ng/ml) Css range.
Trial: 8834418
Drug: C24h prediction
RxNorm normalized name: REDUCTIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C24h prediction formula for maintenance dose of HPDL.
Trial: 1600051
Drug: Hydrocortisone acetate
RxNorm normalized name: Hydrocortisone Acetate
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone acetate foam (Proctocort) administered rectally
Trial: 4017421
Drug: Losulazine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losulazine (10 to 30 mg b.i.d.)
Trial: 31262343
Drug: Repetitive Sensory
RxNorm normalized name: aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Repetitive Sensory Stimulation (RSS) for 45 minutes daily plus usual care for 2 weeks
Trial: 29935486
Drug: Intravenous ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ibuprofen (800 mg every 6 hours for 24 hours)
Trial: 29935486
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen (1 g every 6 hours for 24 hours)
Trial: 27863809
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg LMTM twice a day
Trial: 27863809
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg LMTM twice a day
Trial: 27863809
Drug: Control (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (4 mg LMTM twice a day)
Trial: 20367560
Drug: Ordinary office-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary office-based hypertension treatment protocol (n=68)
Trial: 10626559
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at a dose of 3 IU/m2/day (1 mg/m2/day) (n = 35)
Trial: 7651456
Drug: Tolcapone (50-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolcapone (50-800 mg)
Trial: 7002480
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg tolmetin sodium daily
Trial: 334478
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg indomethacin daily
Trial: 29742904
Drug: Unified Protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified Protocol (UP) treatment modules ordered according to pretreatment strengths
Trial: 29742904
Drug: Unified Protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified Protocol (UP) treatment modules ordered according to pretreatment weaknesses
Trial: 26719805
Drug: Long-term oxygen
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oxygen therapy (LTOT) in COPD patients
Trial: 26719805
Drug: No long-term
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No long-term oxygen therapy (no LTOT) in COPD patients
Trial: 12957222
Drug: Isradipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (10 mg)
Trial: 12957222
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg) + Isradipine (10 mg)
Trial: 12957222
Drug: Isradipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (10 mg) + Naltrexone (50 mg)
Trial: 9278834
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (15 mg hyperbaric bupivacaine + saline)
Trial: 2527542
Drug: Cilazapril 2.5
RxNorm normalized name: cilazapril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 2.5 mg once a day
Trial: 921245
Drug: Ribavirin (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin (1,000 mg/day in four divided doses)
Trial: 30658942
Drug: Asymmetric split-dose
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asymmetric split-dose regimen (25% on the day of colonoscopy and 75% the day before)
Trial: 30658942
Drug: Symmetric split-dose
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symmetric split-dose regimen (standard split-dose)
Trial: 17299499
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (2.7 g long-chain n-3 fatty acids per day from week 20 for groups 1 and 2; 6.3 g from week 33 for group 3)
Trial: 17299499
Drug: Control (olive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (olive oil capsules)
Trial: 11273850
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g American ginseng
Trial: 11273850
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g American ginseng
Trial: 11273850
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g American ginseng
Trial: 11273850
Drug: American ginseng
RxNorm normalized name: American ginseng
DrugBank: Panax quinquefolius whole (DB14296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: American ginseng administered 40 min before glucose challenge
Trial: 9340441
Drug: Nebulizer therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer therapy (0.5 ml ‐ 125 micrograms ipratropium bromide and 250 micrograms phenoterol)
Trial: 9340441
Drug: Aerosol therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol therapy (40 micrograms ipratropium and 100 micrograms phenoterol)
Trial: 1285936
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg nitrendipine twice daily (titrated up to 30 mg twice daily during open label period)
Trial: 3809304
Drug: Clomipramin, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramin, 50 mg (oral)
Trial: 3809304
Drug: Amitriptylin, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptylin, 50 mg (oral)
Trial: 3809304
Drug: Desipramin, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramin, 50 mg (oral)
Trial: 3809304
Drug: Imipramin, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramin, 50 mg (oral)
Trial: 3809304
Drug: Diazepam, 10
RxNorm normalized name: DiazePAM, 10 mg rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam, 10 mg (oral)
Trial: 3809304
Drug: Carbamazepin, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepin, 200 mg (oral)
Trial: 3809304
Drug: Haloperidol, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol, 3 mg (oral)
Trial: 3809304
Drug: Clomipramin, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramin, 25 mg (intravenous)
Trial: 21793769
Drug: Fixed low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fixed low-dose oxytocin
Trial: 21793769
Drug: Standard incremental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard incremental low-dose oxytocin
Trial: 17021740
Drug: Ropivacaine 0.25%
RxNorm normalized name: ROPivacaine 0.25%-NaCl 0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.25% plus 50 mg magnesium
Trial: 11913290
Drug: 6.5% hydrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5% hydrogen peroxide strip system, used twice daily for 30 minutes (total of 56 contact hours over 8 weeks)
Trial: 9707740
Drug: Omeprazole; specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole; specific dosage and duration not mentioned.
Trial: 17068314
Drug: Placebo; specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo; specific dosage and duration not mentioned.
Trial: 8551804
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with < or = 5% residual blasts at D15
Trial: 8551804
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with > 5% residual blasts at D15
Trial: 2246174
Drug: Methacholine inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine inhalation tests in normal subjects
Trial: 2246174
Drug: Methacholine inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine inhalation tests in asthmatic subjects
Trial: 2246174
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg/day) and flurbiprofen (150 mg/day) pretreatment in normal subjects
Trial: 6936982
Drug: treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment with a mixture of 7 grass pollen extracts (Allpyral)
Trial: 6936982
Drug: treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment with a cocksfoot pollen extract (Allpyral)
Trial: 6936982
Drug: treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment with a rye pollen extract (Allpyral)
Trial: 6936982
Drug: treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment with a mixture containing 50% rye pollen and 50% cocksfoot (Allpyral)
Trial: 6936982
Drug: control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control group without immunotherapy
Trial: 24020078
Drug: nCPAP combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nCPAP combined with antireflux medicine (esomeprazole 40 mg/d and mosapride citrate 5 mg, 3 times a day, oral)
Trial: 24020078
Drug: nCPAP combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nCPAP combined with antireflux medicine
Trial: 19645974
Drug: 0.25% levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% levobupivacaine or bupivacaine (Treatment Group)
Trial: 17302060
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) - glucosidorum tripterygll totorum and Yishen Juanbi Pill
Trial: 17302060
Drug: Western Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western Medicine (WM) - non-steroidal anti-inflammatory drugs and slow-acting anti-rheumatic drugs
Trial: 15217308
Drug: Fluvastatin (Lescol)
RxNorm normalized name: fluvastatin Oral Capsule [Lescol]
DrugBank: Fluvastatin (DB01095)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluvastatin (Lescol) 40 mg twice daily plus dietary counselling
Trial: 11216808
Drug: Azathioprine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (4 mg/kg intraoperatively and 2.0 +/- 0.5 mg/kg once daily for 3 months)
Trial: 9773716
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (CEE) at 0.625 mg/day
Trial: 9773716
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) at 2.5 mg daily (continuous MPA)
Trial: 9773716
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) at 10 mg on days 1-12 (cyclical MPA)
Trial: 9773716
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone (MP) at 200 mg on days 1-12 (cyclical)
Trial: 9495426
Drug: Tropisetron 2
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 2 mg
Trial: 7848884
Drug: Tropisetron 5
RxNorm normalized name: tropisetron 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 5 mg (rescue infusion)
Trial: 7848884
Drug: Tropisetron 5
RxNorm normalized name: tropisetron 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 5 mg, 10 mg, 20 mg, 40 mg (study I)
Trial: 3141867
Drug: Active allergen
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active allergen injection during treatment sessions
Trial: 3141867
Drug: Placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injection during treatment sessions
Trial: 3141867
Drug: Neutralization subcutaneous
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutralization subcutaneous treatment
Trial: 28918441
Drug: LSD (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LSD (200 μg)
Trial: 27624148
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg of oral THC twice daily
Trial: 18843961
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) 1 g thrice daily during menstrual cycle days 1-5
Trial: 18843961
Drug: Norethisterone (NET)
RxNorm normalized name: ethisterone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethisterone (NET) 5 mg twice daily on days 19-26
Trial: 8695137
Drug: Nalbuphine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 0.25 mg/kg